HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q1 2024

SEC EDGAR SourceSEC Filings

Top Holdings63 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
PDDPDD
ADR

PDD HOLDINGS INC

11.8M$1.4B29.8%$97.08+19.75%
8 qtrssince 2022-Q2
Increased
72
ONCONC
ADR

BEIGENE LTD-ADR

5.2M$809.6M17.6%$134.02+16.69%
22 qtrssince 2018-Q4
Unchanged
0
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

29.2M$400.7M8.7%$21.97-40.29%
15 qtrssince 2020-Q3
Decreased
0
LEGNLEGN
ADR

Legend Biotech Corp. Sponsored ADR

6M$335.7M7.3%$50.98+10.01%
16 qtrssince 2020-Q2
Unchanged
0

MICROSOFT CORP

692,100$291.2M6.3%$302.56+37.26%
8 qtrssince 2022-Q2
Decreased
0

ADVANCED MICRO DEVICES

912,400$164.7M3.6%$180.49+180.35%
1 qtr
New
84

AMAZON.COM INC

822,900$148.4M3.2%$127.55+41.42%
8 qtrssince 2022-Q2
Increased
56

SALESFORCE.COM INC

462,137$139.2M3.0%$206.97+43.96%
17 qtrssince 2020-Q1
Decreased
0

DANAHER CORP

471,100$117.6M2.6%$225.13+9.87%
4 qtrssince 2023-Q2
Unchanged
0

TAKE-TWO INTERACTIVE SOFTWRE

783,000$116.3M2.5%$145.47+69.76%
4 qtrssince 2023-Q2
Unchanged
0

DOORDASH INC - A

583,463$80.4M1.7%$116.24+18.48%
14 qtrssince 2020-Q4
Decreased
0

ARRIVENT BIOPHARMA INC

3.9M$70.2M1.5%$17.860.00%
1 qtr
New
68

Kiniksa Pharmaceuticals Interna

3.1M$61.9M1.3%$19.73+289.00%
1 qtr
New
67

MOODY'S CORP

155,846$61.3M1.3%$381.99+0.86%
2 qtrssince 2023-Q4
Unchanged
0
ENFNENFNDelisted

ENFUSION INC

5M$46M1.0%
10 qtrssince 2021-Q4
Unchanged
0

CYTEK BIOSCIENCES INC

6.7M$44.7M1.0%$20.96-67.99%
11 qtrssince 2021-Q3
Unchanged
0

BRIDGEBIO PHARMA INC

1.4M$42.3M0.9%$28.25+9.43%
20 qtrssince 2019-Q2
Decreased
0
HTHTHTHT
ADR

H WORLD GROUP LTD

935,920$36.2M0.8%$42.46-15.47%
16 qtrssince 2020-Q2
Unchanged
0

COUPANG INC

1.1M$19.1M0.4%$25.60-30.52%
11 qtrssince 2021-Q3
Decreased
0
BIDUBIDU
ADR

BAIDU INC - SPON ADR

150,600$15.9M0.3%$148.69-29.19%
5 qtrssince 2023-Q1
Decreased
0
$4.6B
AUM
63
Positions
Q1 2024
Filing
Rating · 2.0
Quarterly Portfolio Change
+25%Q4'22$4.7B+19%Q1'23$5.6B-17%Q2'23$4.7B-5%Q3'23$4.5B+11%Q4'23$5B-7%Q1'24$4.6B
Activity profile
$ moved · Q1'24
New36%Increased13%Decreased40%Exited11%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.7 years
<1Q19%1-4Q8%1-2Y6%2Y+67%

HHLR ADVISORS, LTD. manages $4.6B across 63 positions as of Q1 2024. Top holdings: PDD (29.8%), ONC (17.6%), BEKE (8.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q1 2024 Summary

Active quarter - 21 new positions, 7 exits, 2 increased. Top move: AMD (NEW, conviction 84). Portfolio: $4.6B across 63 positions.

Top holdings by portfolio weight

Total AUM$5B
PDD29.77%
ONC17.58%
BEKE8.70%
LEGN7.29%
MSFT6.32%
AMD3.58%
AMZN3.22%
CRM3.02%
DHR2.56%
TTWO2.53%
Other1.75%

Portfolio allocation by GICS sector

Sectors10
Consumer Cyclical36.91%
Healthcare33.02%
Technology14.02%
Real Estate8.70%
Communication Services3.86%
Financial Services1.33%
Unknown1.10%
Consumer Defensive0.62%
Industrials0.44%
Utilities0.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Consumer Cyclical, Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used